Ondansetron (ODFS)
OND/CR/020/08-09
Phase 2 small_molecule completed
Quick answer
Ondansetron (ODFS) for Nausea and Vomiting, Postoperative is a Phase 2 program (small_molecule) at Aquestive Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aquestive Therapeutics
- Indication
- Nausea and Vomiting, Postoperative
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed